Taiwan FDA registration 6edd1f70864a78548608b9ab4f1e4595

Innova CCP immunoglobulin G enzyme linked immunoassay test system

TW: 因諾瓦 CCP 免疫球蛋白 G 酵素連結免疫分析法檢驗系統
Taiwan flagTaiwan·Risk Class 2·INOVA DIANOSTICS, INC.·Registered Dec 30, 2005 – Dec 30, 2015Cancelled
Registration details
Analysis ID
6edd1f70864a78548608b9ab4f1e4595
Customs Code
DHA00601513705
Company information
Manufacturer Country
United States
Authorized Representative
TRUGENE DIAGNOSTICS, INC.
Product details
Intended Use
利用免疫酵素法(Enzyme Linked Immunoassay, ELISA) 進行病患血清檢體內之抗 CCP (cyclic citrullinated peptide 環狀瓜氨酸胜?) 免疫球蛋白 G (IgG) 抗體之半定量檢測.
Product Type (Level 1)
C Immunology and microbiology
Product Type (Level 2)
C.5775 類風濕性因子免疫試驗系統
Import Information
import
Dates and status
Registration Date
Dec 30, 2005
Expiry Date
Dec 30, 2015
Cancellation Date
Aug 09, 2018
Cancellation information
Status
Logged out
Reason
未展延而逾期者
About this record

Access comprehensive regulatory information for Innova CCP immunoglobulin G enzyme linked immunoassay test system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 6edd1f70864a78548608b9ab4f1e4595 and manufactured by INOVA DIANOSTICS, INC.. The authorized representative in Taiwan is TRUGENE DIAGNOSTICS, INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices